tapentadol

chemical compound

Facts

16 properties
Instance of
type of chemical entity
Subclass of
3-(1-(dimethylamino)-2-methylpentan-3-yl)phenol
Active ingredient in
Nucynta
Canonical SMILES
CCC(C1=CC(=CC=C1)O)C(C)CN(C)C[5]
Chemical formula
C₁₄H₂₃NO[6]
Defined daily dose
0.4 g
Described by source
Opium Law
Isomeric SMILES
CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C
Legal status (medicine)
boxed warning
Mass
221.177964 Da
Medical condition treated
fibromyalgia
Pregnancy category
Australian pregnancy category C, US pregnancy category C
Substance control status
Schedule 8 (Australia), Schedule I (Canada), Anlage III (Germany), Schedule II (United States)
🏷️ Also known as
en Tapentadol en Nucynta® en Palexia® en tapentadol en BN-200 en CG-5503 ar تابينتادول de Palexia el Ταπενταδόλη fi Palexia fi tapentadoli he טפנטדול it tapentadolo ja タペンタドール ko 타펜타돌 ru Тапентадол sv Palexia zh 他喷他多 zh 他噴他竇
🔖 Identifiers · 36
OpenAlex ID
C2780505013
ATC code
N02AX06
CAS Registry Number
175591-23-8
ChEBI ID
135935
ChEMBL ID
CHEMBL1201776
ChemSpider ID
8013742
DSSTOX compound identifier
DTXCID1092494
DSSTox substance ID
DTXSID30170003
DeCS ID
57647
DrugBank ID
DB06204
DrugCentral ID
4283
Show all 36 identifiers +24
EC number
605-757-6
ECHA Substance Infocard ID
100.131.247
Freebase ID
/m/03c21nw
Guide to Pharmacology Ligand ID
7477
HSDB ID
8309
KEGG ID
D06007
MeSH concept ID
M0515162
MeSH descriptor ID
D000077432
MedlinePlus drug identifier
a610006
Microsoft Academic ID (discontinued)
2780505013
NDF-RT ID
N0000179820
NSC number
759619
PatientsLikeMe treatment ID
tapentadol
Probes And Drugs ID
PD009322
PubChem CID
9838022
RxNorm CUI
787390
SureChEMBL ID
116924
UMLS CUI
C2001271
UniChem compound ID
512593
WikiProjectMed ID
Tapentadol

Report an error or request removal Lineage (PROV-JSON)

🔗 Connections
Significant drug interaction 109
← Significant drug interaction 105
Has use 1
Legal status (medicine) 1
Medical condition treated 1
Press Enter · cited answer in seconds

Summary

tapentadol is a type of chemical entity[1]. tapentadol is a type of 3-(1-(dimethylamino)-2-methylpentan-3-yl)phenol[2].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [3] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  2. [4] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  3. [5] ↑ . PubChem. Retrieved . wikidata.org.
  4. [6] ↑ . PubChem. Retrieved . wikidata.org.
  5. [2] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . High-priority drug–drug interactions for use in electronic health records. wikidata.org.
  8. [9] ↑ . High-priority drug–drug interactions for use in electronic health records. wikidata.org.
  9. [10] ↑ . High-priority drug–drug interactions for use in electronic health records. wikidata.org.
  10. [11] ↑ . High-priority drug–drug interactions for use in electronic health records. wikidata.org.
  11. [12] ↑ . High-priority drug–drug interactions for use in electronic health records. wikidata.org.
  12. [13] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  13. [14] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  14. [15] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  15. [16] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  16. [17] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  17. [18] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  18. [19] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  19. [20] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  20. [21] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). tapentadol. Retrieved November 14, 2026, from https://4ort.xyz/entity/tapentadol
MLA “tapentadol.” 4ort.xyz Knowledge Graph, 4ort.xyz, 14 Nov. 2026, https://4ort.xyz/entity/tapentadol.
BibTeX @misc{4ortxyz_tapentadol_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{tapentadol}}, year = {2026}, url = {https://4ort.xyz/entity/tapentadol}, note = {Accessed: 2026-11-14}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): tapentadol — https://4ort.xyz/entity/tapentadol (retrieved 2026-11-14)

Canonical URL: https://4ort.xyz/entity/tapentadol · Last refreshed:

Edit History

Rolling log of changes to this entity's Wikidata record. Values shown reflect the current state of each edited property — follow the history link to see the precise diff for any edit.

  1. 4d ago · DaSupremo · 2026-11-14 view diff on Wikidata ↗
    Substance control status → Schedule 8 (Australia), Schedule I (Canada), Anlage III (Germany) +1
    GND ID → 1175545015
    "Added [gpe] label: tapentadol"
  2. 11w ago · Carn · 2026-08-31 view diff on Wikidata ↗
    Substance control status → Schedule 8 (Australia), Schedule I (Canada), Anlage III (Germany) +1
    "Created claim: Substance control status: Schedule 8 (Australia), batch #269907"
  3. 21w ago · Nabbegat · 2026-06-19 view diff on Wikidata ↗
    Defined daily dose → 0.4 gram
    Legal status (medicine) → boxed warning
    Instance of → type of chemical entity
    Has use → medication
    + 8 other properties edited (see Wikidata diff for full list)
    "Changed [tr] labels, descriptions or aliases: QuickStatements 3.0 batch #37300"
Live feed via Wikidata EventStreams. New edits appear within minutes of being made on Wikidata.